Piperacillin/tazobactam plus tobramycin versus ceftazidime plus tobramycin for the treatment of patients with nosocomial lower respiratory tract infection
Manjari Joshi, Jack Bernstein, Joseph Solomkin, Barbara Ann Wester, Olatunde Kuye, A. Erickson, R. A. Khakoo, B. Suh, J. Wellman, S. Jenkinson, C. Crim, N. Kirmani, D. Smith, D. W. Gump, G. T. Valainis, L. A. Von Behren, W. J. Holloway, B. E. Sieger, M. A. Young, S. J. Goodnight-WhiteP. S. Barie, L. D. Thrupp, T. J. Louie, D. Grimard, A. Y. Martel, S. Lambert, R. Boileau
Dive into the research topics of 'Piperacillin/tazobactam plus tobramycin versus ceftazidime plus tobramycin for the treatment of patients with nosocomial lower respiratory tract infection'. Together they form a unique fingerprint.